The Journal of Allergy and Clinical Immunology
Volume 117, Issue 6 , Pages 1382-1388, June 2006

Nasal inflammation and personal exposure to fine particles PM2.5 in asthmatic children

  • Lydia Nikasinovic, PhD

      Affiliations

    • From Service de Santé Publique-Environnement, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes
    • Corresponding Author InformationReprint requests: Lydia Nikasinovic, PhD, Service de Santé Publique-Environnement, Faculté de Pharmacie, 4, avenue de l'Observatoire, 75270 Paris cedex 06, France.
  • ,
  • Jocelyne Just, PhD

      Affiliations

    • From Service de Santé Publique-Environnement, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes
    • Service de Pneumologie et d'Allergologie Pédiatrique, Hôpital d'Enfants Armand Trousseau, Assistance Publique-Hôpitaux de Paris
  • ,
  • Fatiha Sahraoui, MD

      Affiliations

    • Service de Pneumologie et d'Allergologie Pédiatrique, Hôpital d'Enfants Armand Trousseau, Assistance Publique-Hôpitaux de Paris
  • ,
  • Nathalie Seta, PhD

      Affiliations

    • From Service de Santé Publique-Environnement, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes
  • ,
  • Alain Grimfeld, MD

      Affiliations

    • Service de Pneumologie et d'Allergologie Pédiatrique, Hôpital d'Enfants Armand Trousseau, Assistance Publique-Hôpitaux de Paris
  • ,
  • Isabelle Momas, PhD

      Affiliations

    • From Service de Santé Publique-Environnement, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes

Received 17 January 2005; received in revised form 2 March 2006; accepted 10 March 2006.

Paris, France

Background

Outdoor and indoor air pollutants are suspected to induce harmful effects on respiratory health, raising the question of their involvement in allergic asthma and rhinitis.

Objective

The potential effect of short-term personal exposure to particulate matter with a diameter of less than 2.5 μm (PM2.5) on nasal inflammation was examined in children living in the Paris area.

Methods

Forty-one children with allergic asthma and 44 healthy children participated in this study. They were monitored during 48 hours for their personal exposure to PM2.5. At the end of the measurement period, children underwent one nasal lavage. Nasal lavage fluid was investigated for cellular (neutrophils and eosinophils) and soluble (albumin, urea, elastase, α1-antitrypsin, IL-6, and IL-8) mediators.

Results

Pollutant concentrations did not differ between the 2 groups. In asthmatic subjects, but not in healthy children, personal PM2.5 levels were correlated to nasal percentage of eosinophils and to albumin, urea, and α1-antitrypsin concentrations after adjustment for confounders (age, sex, house dust mites, pollens, cat, environmental tobacco smoke through urinary cotinine, barometric pressure, and respiratory infection).

Conclusion

The association observed with the percentage of eosinophils supports recent speculations on fine particle involvement in allergic phenotype overexpression.

Clinical implications

This study highlights the link between personal fine particle exposures and nasal inflammation in asthmatic allergic children living in urban areas. Because the view of united airways is still not completely understood, the question of pulmonary inflammation in such a situation deserves further investigation.

Key words: Nasal lavage fluid, inflammation, allergy, asthma, eosinophil, children, personal exposure, fine particle, PM2.5

Abbreviations used: DEP, Diesel exhaust particle, ETS, Environmental tobacco smoke, NAL, Nasal lavage, NALF, Nasal lavage fluid, PM, Particulate matter, PM2.5, Particulate matter with diameter less than 2.5 μm, PM10, Particulate matter with diameter less than 10 μm

 

 Supported by the French research Program on air pollution (PRIMEQUAL/PREDIT) coordinated by the Ministry of Environment. Lydia Nikasinovic received a doctoral grant from Agence de l'Environnement et de la Maîtrise de l'Énergie (Paris, France). Also supported by Assistance Publique-Hôpitaux de Paris (Paris, France) and Laboratoire Novartis (Rueil-Malmaison, France) and Laboratoire MSD (Paris, France).Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(06)00729-9

doi:10.1016/j.jaci.2006.03.023

The Journal of Allergy and Clinical Immunology
Volume 117, Issue 6 , Pages 1382-1388, June 2006